generics

FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
Endpoints
FDA
Amarin
Vascepa
Hikma
generics
Flag link:
Bangladesh pharma claims to be first to launch generic remdesivir
Bangladesh pharma claims to be first to launch generic remdesivir
BioPharma Dive
Bangladesh
Beximco
generics
remdesivir
Gilead Sciences
COVID-19
Flag link:
Generic drugmaker Akorn files for bankruptcy
Generic drugmaker Akorn files for bankruptcy
Beckers Hospital Review
Akorn
generics
bankruptcy
Flag link:
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Teva Pharmaceutical
price fixing
generics
COVID-19
Sandoz
JNJ
Novartis
Taro Pharmaceuticals
Flag link:
What COVID-19 means for generics companies
What COVID-19 means for generics companies
Pharmaforum
COVID-19
pandemic
generics
Flag link:
Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
Fierce Pharma
Gilead Sciences
generics
drug manufacturing
COVID-19
remdesivir
Flag link:
COVID-19 restrictions send generic drug shipping costs through the roof: survey
COVID-19 restrictions send generic drug shipping costs through the roof: survey
Fierce Pharma
COVID-19
generics
biosimilars
drug manufacturing
Flag link:
FDA guides generic drugmakers on bioequivalence study disruptions amid COVID-19
FDA guides generic drugmakers on bioequivalence study disruptions amid COVID-19
RAPS.org
FDA
generics
bioequivalence studies
COVID-19
pandemic
Flag link:
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
Flag link:
FDA Offers Guidance for Generic Drug Developers of Hydroxychloroquine, Chloroquine
FDA Offers Guidance for Generic Drug Developers of Hydroxychloroquine, Chloroquine
RAPS.org
FDA
COVID-19
hydroxychloroquine sulfate
chloroquine phosphate
generics
Flag link:
Blackstone backs Alnylam with up to $2B investment
Blackstone backs Alnylam with up to $2B investment
BioPharma Dive
generics
Alnylam
Blackstone
RNAi
Flag link:
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
Stat
Axcella Health
WHO
Novartis
generics
drug repurposing
COVID-19
Flag link:
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Novartis
generics
Sandoz
antitrust
Flag link:
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Fierce Pharma
Amarin
Vascepa
generics
patents
Flag link:
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
Stat
AbbVie
Kaletra
generics
Israel
COVID-19
Flag link:
Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports
Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports
Endpoints
Donald Trump
COVID-19
generics
Rising Pharmaceuticals
drug pricing
chloroquine phosphate
Flag link:
Coronavirus spurs India to restrict exports of 2 dozen drugs
Coronavirus spurs India to restrict exports of 2 dozen drugs
Fierce Pharma
generics
India
coronavirus
COVID-19
Flag link:
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Sandoz
generics
Novartis
antitrust
Flag link:
The FDA OKs generic Daraprim, the Martin Shkreli therapy that triggered an unending tempest over drug pricing
The FDA OKs generic Daraprim, the Martin Shkreli therapy that triggered an unending tempest over drug pricing
Endpoints
FDA
generics
Daraprim
Martin Shkreli
Flag link:
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Sandoz
generics
antibiotics
COVID-19
coronaviruses
Flag link:

Pages